Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, and breadth of cytotoxic t-cell lymphocyte response during chronic HIV-1 infection

Clinical Infectious Diseases

Volumn 54, Issue 2, 2012, Pages 294-302

  Naicker, Dshanta D ^a   Wang, Bingxia ^b   Losina, Elena ^b   Zupkosky, Jennifer ^d   Bryan, Susan ^a   Reddy, Shabashini ^a   Jaggernath, Manjeetha ^a   Mokgoro, Mammekwa ^a   Goulder, Philip J R ^c   Kaufmann, Daniel E ^b,d   Ndung'U, Thumbi ^a,d  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LOSS; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; VIRUS REPLICATION;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 84555206609     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir811     Document Type: Article

References (39)

1. UNAIDS. AIDS epidemic update. UNAIDS, 2009. Available at: http://www.unaids.org/en/dataanalysis/epidemiology/2009aidsepidemicupdate/.
2. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a doubleblind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-93.
3. McElrath MJ, De Rosa SC, Moodie Z, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008; 372:1894-905.
4. Trinvuthipong C. Thailand's Prime-boost HIV vaccine phase III. Science 2004; 303:954-5. (Pubitemid 38209684)
5. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-51. (Pubitemid 37386411)
6. Shrestha S, Strathdee SA, Galai N, et al. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis 2006; 193:16-26. (Pubitemid 43033317)
7. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996; 2:412-17. (Pubitemid 26191912)
8. Kostrikis LG, Neumann AU, Thomson B, et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999; 73:10264-71.
9. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432:769-75.
10. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-7. (Pubitemid 47301321)
11. Limou S, Le Clerc S, Coulonges C, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199:419-26.
12. Basxtürk B, Tunali A, Karakus S. Interleukin-10 and interferon-gamma cytokine gene polymorphisms may be risk factors for chronic myelogenous leukemia. Turkish J Haemotol 2005; 22:191-6. (Pubitemid 43263465)
13. Lech-Maranda E, Baseggio L, Bienvenu J, et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004; 103:3529-34. (Pubitemid 38525688)
14. Filippi CM, von Herrath MG. IL-10 and the resolution of infections. J Pathol 2008; 214:224-30. (Pubitemid 351160159)
15. Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92:3943-8. (Pubitemid 28525221)
16. Ness RB, Haggerty CL, Harger G, Ferrell R. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am J Epidemiol 2004; 160:1033-8. (Pubitemid 39557455)
17. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86:515-81.
18. Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, et al. Reduced mortality and CD4 cell loss among carriers of the interleukin-10-1082G allele in a Zimbabwean cohort of HIV-1-infected adults. AIDS 2007; 21:2283-91. (Pubitemid 350287454)
19. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166:3915-22. (Pubitemid 32224918)
20. Oleksyk TK, Shrestha S, Truelove AL, et al. Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun 2009; 10:309-22.
21. Shin HD, Winkler C, Stephens JC, et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 2000; 97:14467-72. (Pubitemid 32016599)
22. Eskdale J, Gallagher G, Verweij CL, Keijsers V,Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95:9465-70. (Pubitemid 28506254)
23. Kamali-Sarvestani E, Kiany S, Gharesi-Fard B, Robati M. Association study of IL-10 and IFN-gamma gene polymorphisms in Iranian women with preeclampsia. J Reprod Immunol 2006; 72:118-26. (Pubitemid 44692312)
24. Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006; 107:4101-8. (Pubitemid 43726819)
25. Vasilescu A, Heath SC, Ivanova R, et al. Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression. Genes Immun 2003; 4:441-9. (Pubitemid 38967609)
26. Naicker DD, Werner L, Kormuth E, et al. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 2009; 200:448-52.
27. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12:1301-9. (Pubitemid 44706933)
28. Ejrnaes M, Filippi CM, Martinic MM, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006; 203:2461-72. (Pubitemid 44664616)
29. Brockman MA, Kwon DS, Tighe DP, et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009; 114:346-56.
30. Alter G, Kavanagh D, Rihn S, et al. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J Clin Invest 2010; 120:1905-13.
31. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD81 T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53. (Pubitemid 46067385)
32. Goulder PJ, Addo MM, Altfeld MA, et al. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by ELISPOT and intracellular cytokine staining assays. J Virol 2001; 75:1339-47. (Pubitemid 32094692)
33. Wilkie AO. The molecular basis of genetic dominance. J Med Genet 1994; 31:89-98. (Pubitemid 24056438)
34. Herbein G, Varin A. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 2010; 7:33.
35. Martinic MM, von Herrath MG. Novel strategies to eliminate persistent viral infections. Trends Immunol 2008; 29:116-24.
36. Ancuta P, Bakri Y, Chomont N, Hocini H, Gabuzda D, Haeffner-Cavaillon N. Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains. J Immunol 2001; 166:4244-53. (Pubitemid 32224960)
37. Bento CA, Hygino J, Andrade RM, et al. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment. AIDS 2009; 23:9-18.
38. Wang Y, Rice AP. Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology 2006; 352:485-92. (Pubitemid 44216010)
39. Wong JK, Campbell GR, Spector SA. Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins. J Biol Chem 2010; 285:18319-25.